Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The novel nano-selenium supplement extends lifespan and delays multi-organs aging by regulating the Sik1 pathway through maintaining calcium homeostasis

ABSTRACT: Aging involves progressive physiological decline and increased disease susceptibility, creating demand for effective interventions. While selenium regulates redox homeostasis and aging, its therapeutic use is limited by bioavailability and toxicity. We developed diselenide-bridged mesoporous silica nanoparticles (SeMSNs) as a novel delivery system. SeMSNs delayed cellular senescence in fibroblasts and H₂O₂-induced models by reducing oxidative stress and senescence markers (p16, p21). In aged mice, SeMSNs extended lifespan, reduced frailty, and improved multiple age-related conditions including muscle atrophy, renal dysfunction, cognitive decline, and hepatic steatosis while restoring metabolic balance. Mechanistically, SeMSNs upregulated selenoproteins (GPx1, SelK), restored calcium homeostasis, attenuated ER stress, and inhibited NFATc2-mediated Sik1 transcription. Clinical data showed inverse correlations between selenium levels and aging biomarkers. SeMSNs also rejuvenated human adipose progenitor cells via calcium-NFATc2-Sik1 modulation. These findings reveal SeMSNs surpass conventional antioxidants by targeting selenium-calcium crosstalk, providing a translatable nanotherapeutic strategy for multi-organs aging intervention and healthy longevity through selenium's molecular mechanisms.

ORGANISM(S): Mus musculus

PROVIDER: GSE303490 | GEO | 2026/07/12

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Phosphorylation of SIK1 by Akt1 activates STAT3 signal pathway in breast cancer cell.

Project description:As a member of AMPK-related kinases, salt-inducible kinase 1 (SIK1) regulates energy response-related physiopathological processes, such as gluconeogenesis and lipid metabolism. More recently, instead of AMPK, SIK1 has been strikingly defined as a major player for tumor suppressor liver kinase 1 (LKB1) deficient NSCLC. However, the exact roles and upstream regulators of SIK1 in breast cancer are not well defined.We found that Akt1 can directly phosphorylate SIK1 and inhibit the kinase activity of SIK1, promoting the progress of breast cancer. To investigate the mechanism of Akt1 phosphorylated SIK1 promoting the progression of breast cancer, we constructed a stable expression of SIK1 WT and S435D in BT549, and then performed gene expression profiling analysis.

2024-07-01 | GSE223214 | GEO

The novel nano-selenium supplement extends lifespan and delays multi-organs aging by regulating the Sik1 pathway through maintaining calcium homeostasis

Project description:The novel nano-selenium supplement extends lifespan and delays multi-organs aging by regulating the Sik1 pathway through maintaining calcium homeostasis

| PRJNA1295520 | ENA

Manual therapy improves fibromyalgia symptoms by downregulating SIK1

Project description:Fibromyalgia (FM), classified by ICD-11 with code MG30.0, is a chronic debilitating disease characterized by wide-spread pain, fatigue, cognitive impairment, sleep and intestinal alterations, among other. FM affects a large proportion of the world-wide population, with increased prevalence among women. The lack of understanding of its etiology and pathophysiology hampers the development of effective treatments. Our group had developed a manual therapy (MT) pressure-controlled custom manual protocol on FM showing hyperalgesia/allodynia, fatigue and patient’s quality of life benefits in a cohort of 38 FM cases (NCT04174300). With the aim of understanding the therapeutic molecular mechanisms triggered by MT, this study interrogated PBMC transcriptomes from FM participants of this clinical trial using RNAseq and RT-qPCR technologies. The results showed that the salt-induced kinase SIK1 gene was consistently downregulated by MT in FM, correlating with improvement of patient symptoms. In addition, the study compared the findings in a non-FM control cohort subjected to the same MT protocol evidencing that changes in SIK1 expression with MT only occurred in individuals with FM. This positions SIK1 as a potential biomarker to monitor response to MT, and as a therapeutic target of FM, to be further explored by continuation studies. Keywords: fibromyalgia; myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); pressure point threshold (PPT); physiotherapy; manual therapy (MT); NCT04174300; SIK1

2024-09-11 | GSE274134 | GEO

Single cell RNA seq analysis of LPS-stimulated PBMCs pre-treated with JRD-SIK1/2i-3

Project description:The Salt-Inducible Kinases (SIK) 1-3 are key regulators of pro- versus anti-inflammatory cytokine responses during innate immune activation. The lack of highly SIK-family or SIK isoform-selective inhibitors suitable for repeat, oral dosing has limited the study of which SIK isoforms need to be targeted to suppress inflammation in vivo. To overcome this challenge, we devised a structure-based design strategy for developing potent SIK inhibitors that are highly selective against other kinases by engaging two differentiating features of the SIK catalytic site. This effort resulted in SIK1/2-selective probes that inhibit key intracellular proximal signaling events including reducing phosphorylation of the SIK substrate cAMP response element binding protein (CREB) regulated transcription coactivator 3 (CRTC3) 3 as detected with a newly generated phospho-Ser329-specific antibody. These inhibitors also suppress production of pro-inflammatory cytokines while inducing anti-inflammatory interleukin-10 in activated human and murine myeloid cells as well as in mice following a lipopolysaccharide challenge. To define the functional effects of SIK1/2 inhibitors in primary human immune cells, we profiled the transcriptional responses elicited by SIK1/2-selective probe JRD-SIK1/2i-3 in peripheral blood mononuclear cells (PBMCs) isolated from healthy donors responding to TLR4 activation at single cell resolution.

2023-12-25 | GSE249669 | GEO

Manual therapy improves fibromyalgia symptoms by downregulating SIK1

Project description:Manual therapy improves fibromyalgia symptoms by downregulating SIK1

| PRJNA1145016 | ENA

Mitochondrial Calcium Uniporter Promotes Kidney Aging through Inducing Mitochondrial Calcium-Mediated Renal Tubular Cell Senescence

Project description:Kidney is a vital organ responsible for homeostasis in the body. To retard kidney aging is of great importance for maintaining body health. Whereas the therapeutic strategies targeting against kidney aging are not elucidated. Recent studies show mitochondrial dysfunction is critical for renal tubular cell senescence and kidney aging, however, the underlying mechanisms of mitochondrial dysfunction in kidney aging have not been demonstrated. Herein, we found calcium overload, and the mitochondrial calcium uniporter (MCU) was induced in renal tubular cells and aged kidney. To activate MCU not only triggered mitochondrial calcium overload, but also induced reactive oxygen species (ROS) production and cellular senescence and age-related kidney fibrosis. Inversely, to block MCU or chelate calcium diminished ROS generation, restored mitochondrial homeostasis, and retarded cell senescence and protected against kidney aging. These results demonstrate MCU plays a key role in promote renal tubular cell senescence, which provides a new insight on the therapeutic strategy for fighting against kidney aging.

2024-10-02 | GSE262514 | GEO

Project description:Decline in tissue NAD levels during aging has been linked to aging-associated diseases, such as age-related metabolic disease, physical decline, and Alzheimers disease. However, the mechanism for aging-associated NAD decline remains unclear. Here we report that pro-inflammatory M1 macrophages, but not naive or M2 macrophages, highly express the NAD consuming enzyme CD38 and have enhanced CD38-dependent NADase activity. Furthermore, we show that aging is associated with enhanced inflammation due to increased senescent cells, and the accumulation of CD38 positive M1 macrophages in visceral white adipose tissue. We also find that inflammatory cytokines found in the supernatant from senescent cells (Senescence associated secretory proteins, SASP) induces macrophages to proliferate and express CD38. As senescent cells progressively accumulate in adipose tissue during aging, these results highlight a new causal link between visceral tissue senescence and tissue NAD decline during aging and may present a novel therapeutic opportunity to maintain NAD levels during aging.

2019-04-25 | MSV000083726 | MassIVE

Soluble DLK1 secreted by telomere-shortening-induced senescent microglia impairs oligodendrocyte functions and alters neuronal activity [DLK1_snRNA-seq]

Project description:Aging is a predominant risk factor of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Here, we investigated the impact of telomere shortening, a physiological hallmark of aging, on brain function. Telomere-shortened mice exhibited cognitive decline and exacerbated lipofuscinosis, accompanied by the emergence of senescent microglia with a senescence-associated secretory phenotype and oligodendrocyte lineage cells with impaired maturation. Using iPSC-derived microglia with shortened telomeres, we identified DLK1 as a novel senescence-associated ligand secreted by senescent microglia. Elevated soluble DLK1 was detected in the cerebrospinal fluid of both telomere-shortened and physiologically aged mice, and this increase was abolished by microglial depletion, confirming its microglial origin. Functionally, AAV-mediated expression of sDLK1 in mouse brains induced hypomyelination and disrupted oligodendrocyte differentiation in vivo. In human iPSC-derived systems, sDLK1 impaired late-stage oligodendrocyte maturation and disrupted neuronal calcium signaling. Together, these findings establish replicative microglial senescence as a pathological feature of telomere shortening and identify sDLK1 as one key effector linking senescent microglia to oligodendrocyte dysfunction and neuronal dysregulation during brain aging.

2026-07-09 | GSE315101 | GEO

Soluble DLK1 secreted by telomere-shortening-induced senescent microglia impairs oligodendrocyte functions and alters neuronal activity(ipsc_cell)

2026-07-09 | GSE315100 | GEO

Deciphering the Role of IGFBP5 in Delaying Fibrosis and Sarcopenia in Aging Skeletal Muscle

Project description:D-galactose (D-gal) is a widely used chemical to induce cellular senescence. Cells undergoing senescence induced by D-gal exhibit mitochondrial structural damage and a decline in energy metabolism, which are highly related to cellular aging Studies have confirmed that D-gal can induce senescence, fibrosis, and redox imbalance in skeletal muscle fibroblasts. Our results confirm that D-galactose effectively induces cellular senescence and skeletal muscle fibrosis in both cellular and animal models. The increase in senescence markers and fibrosis-related proteins, along with the observed decline in muscle strength and mass, are consistent with previous studies that highlight the role of D-galactose in modeling aging-associated pathologies. The observed lethargy and reduction in muscle fiber cross-sectional area further validate the model's relevance to sarcopenia research.

2025-01-09 | GSE285869 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data